08:30-08:55 Vitallink symposium Session 201+202 
Vitallink symposium 
Moderator(s) Sangil Min (Korea)
08:30-08:35 Opening Remarks Curie Ahn (Korea) 
08:35-08:40 Congratulatory Address Soon Il Kim (Korea) 
08:40-08:55 2018 Vitallink Report Summary Curie Ahn (Korea) 
 
08:55-09:55 Vitallink symposium 1 Session 201+202 
Potential Deceased Donor Management in Asia 
Moderator(s) In Sung Moon (Korea), Nancy Ascher (USA)
08:55-09:10 Potential brain death organ donors cases in Bangladesh Jae-myeong Lee (Korea) 
09:10-09:25 Brain death organ donor liver transplantation cases in Myanmar Tin Tin Mar (Myanmar) 
09:25-09:40 Potential brain death organ donors cases in India Vivek B. Kute (India) 
09:40-09:55 Potential brain death organ donors cases in Mongolia Batchuluun Pandaan (Mongolia) 
 
09:55-10:20  Coffee break 300 B+C 
 
10:20-11:25 Vitallink symposium 2 Session 201+202 
Life Sharing-Organ Transplantation Education for Teenagers & Medical Students 
Moderator(s) Yeong Hoon Kim (Korea), Marcelo Cantarovich (Canada)
10:20-10:40 Recent global progress in life sharing-organ transplantation education Jeremy Chapman (Australia) 
10:40-10:55 Role of the TTS in education on organ donation and transplantation for school children Marcelo Cantarovich (Canada) 
10:55-11:10 Experience in the development of teenager school education program Jieun Oh (Korea) 
 
11:25-12:30 Vitallink symposium 3 Session 201+202 
Public Awareness and Respectful attitudes towards the donor and the familyrespectful treatment 
Moderator(s) Samuel Lee (Korea), Khin Maung Htay (Myanmar)
11:25-11:40 How to Honor Organ Donor and their Family Sunyoung Son (Korea) 
11:40-12:00 Recent Progress for the Spread of Donation Culture in Australia Philip O'Connell (Australia) 
12:00-12:15 Public Promotion Activities in Mongolia Battsetseg Gonchigjav (Mongolia) 
12:15-12:30 Non-financial way of expressing respect for donor family Nancy Ascher (USA) 
 
12:30-13:30  Luncheon symposium 1 (GC Pharma) Session 201+202 
Moderator(s) Dong-Lak Choi (Korea)
12:30-13:30 Hepatitis B Immunoglobulin Prophylaxis after Liver Transplantation Joo-Dong Kim (Korea) 
 
12:30-13:30  Luncheon symposium 2 (Sanofi Genzyme) Session 203+204 
Moderator(s) Yeong Hoon Kim (Korea)
12:30-13:30 Hot topics in Kidney transplantation Dorry Segev (USA) 
 
13:30-15:00 PG course 1 (Kidney) Session 201+202 
What's hot in clinical and anatomical pathology
Moderator(s) Yong Jin Kim (Korea), Jong Soo Lee (Korea)
13:30-14:00 NGS application for HLA typing or Higher resolution of HLA typing - is it necessary for organ transplant Younhee Park (Korea) 
14:00-14:30 Clinical Relevance of Non-HLA antibodies Kyu Ha Huh (Korea) 
14:30-15:00 Evolving criteria for the diagnosis of antibody-mediated rejection in kidney allografts Kazuho Honda (Japan) 
 
13:30-15:00 PG course 2 (Basic) Session 203+204 
Innate T lymphocytes: development and activation 
Moderator(s) Tae Jin Kim (Korea)
13:30-14:00 Development of innate T lymphocytes You Jeong Lee (Korea) 
14:00-14:30 Innate and adaptive Gamma-delta T cells Tae Jin Kim (Korea) 
14:30-15:00 Transcription factors in T cell activation and development Yoontae Lee (Korea) 
 
13:30-15:30 PG course 3 (교육위원회) Session 205+206 
Pharmacological update in solid organ transplant patients 
Moderator(s) Sang Il Kim (Korea)
13:30-13:50 Current trends of immunosuppressive agents after organ transplantation Jae Geun Lee (Korea) 
13:50-14:10 Prophylaxis protocol for post-transplant opportunistic infection Kyungmin Huh (Korea) 
14:10-14:30 Perioperative immunization for organ transplant recipient Jonghun Kim (Korea) 
14:30-14:50 Antiviral agents against viral hepatitis after solid organ transplantation Young Youn Cho (Korea) 
14:50-15:00 Q & A  
 
15:00-15:30  Coffee break 300B+C 
 
15:30-17:00 PG course 4 (Kidney) Session 201+202 
Managing the metabolic complication in kidney transplantation 
Moderator(s) Chang-Kwon Oh (Korea), Joong Kyung Kim (Korea)
15:30-16:00 Management and prevention of obesity after kidney transplantation Cheng-Hsu Chen (Taiwan) 
16:00-16:30 Efficacy and safety of new antidiabetic drugs in kidney transplant recipients Byung Ha Chung (Korea) 
16:30-17:00 Update of post-transplant bone disease: hyperparathyroidism, osteoporosis, and avascular necrosis Gang-Jee Ko (Korea) 
 
15:30-17:00 PG course 5 (Liver) Session 203+204 
Roads to be an expert: This is the way I developed myself 
Moderator(s) Hee Jung Wang (Korea), Ki-Hun Kim (Korea)
15:30-15:50 Living donor hepatectomy Kenneth Siu Ho Chok (Hong Kong) 
15:50-16:10 Recipient hepatectomy Toru Ikegami (Japan) 
16:10-16:30 Bench surgery and outflow reconstruction Dong-Hwan Jung (Korea) 
16:30-16:50 Artery anastomosis Dong-Sik Kim (Korea) 
16:50-17:00 Discussion  
 
15:30-17:00 PG course 6 (교육위원회) Session 205+206 
Natural course of living donor 
Moderator(s) Hyung Joon Ahn (Korea)
15:30-15:50 Postoperative complications in living donor Jae Do Yang (Korea) 
15:50-16:10 Social activity and support for living donors/td> Ik Jin Yun (Korea) 
16:10-16:30 Natural course of living kidney donors Sik Lee (Korea) 
16:30-16:50 Natural course of living liver donors Jin Yong Choi (Korea) 
 
17:00-17:30  KST Board Meeting Session 201+202 
 
17:30-19:00  WIT Session & Network Event Session 203+204 
Moderator(s) Curie Ahn (Korea), Yeong Hoon Kim (Korea)
17:30-17:40 Woman in Transplantation: Sharing Malaysian experience Rosnawati Yahya (Malaysia) 
17:40-17:50 Mongolian Womans in Transplantation Lkhaakhuu Od-erdene (Mongolia) 
17:50-18:00 Discussion: The Impact of Mentorship Khin Thida Thwin (Myanmar) 
18:00-18:10 WIT Presentation and Thank You Yeong Hoon Kim (Korea) 
18:10-19:00 Networking Event
 
08:00-08:30  Opening Ceremony Session 300A 
 
08:30-09:30  Keynote Lecture 1 (Kidney/Thoracic) Session 300A 
Moderator(s) Jeremy Chapman (Australia), Jongwon Ha (Korea)
08:30-09:00 Expanding the donor pool with expanded criteria and other risk donors Marcelo Cantarovich (Canada) 
09:00-09:30 Chronic lung allograft dysfunction Lianne Singer (Canada) 
 
09:30-10:30  Plenary Session 1 (Best Papers) Session 300A 
Moderator(s) Philip O'Connell (Australia), Jae-Won Joh (Korea)
09:30-09:45 Self in vivo production of a synthetic biological drug anti-CD25/IL-10 using minicircle vector YooJin Shin (Korea) 
09:45-10:00 Progressive Chronic Kidney Disease Depending on Renal Recovery after Living Kidney Donation Yaerim Kim (Korea) 
10:00-10:15 Ischemia-free liver transplantation facilitates successful transplantation of extended criteria donor livers Shanzhou Huang (China) 
10:15-10:30 The Long-term Efficacy of de novo Everolimus Immunosuppression to Prevent Cardiac Allograft Vasculopathy in Heart Transplant Recipients Hyo-In Choi (Korea) 
 
10:30-10:50  Coffee break 300 B+C 
 
10:50-11:10  KST General Assembly Session 300A 
 
11:10-12:10  KST 50th Anniversary Ceremony Session 300A 
 
12:10-13:00  Luncheon symposium 3 (Astellas) Session 300A 
Moderator(s) Chang-Kwon Oh (Korea), Jong Soo Lee (Korea)
12:40-13:30 Discussing Current Concerns on dnDSA, and The Association with TAC Level Variance and Adherence Daniel Seron (Spain) 
 
13:00-14:30 Concurrent Symposium 1 (Kidney) Session 201+202 
Liver The concept of coming back : Ischemic reperfusion injury in kidney transplantation 
Moderator(s) Sang-Ho Lee (Korea), Cheng-Hsu Chen (Taiwan)
13:00-13:30 Primary non-function and delayed graft function after kidney transplantation Sangil Min (Korea) 
13:30-14:00 Update on ischemia-reperfusion injury in kidney transplantation Ju-Young Moon (Korea) 
14:00-14:30 Clinical application of machine perfusion in kidney transplantation Suphamai Bunnapradist (USA) 
 
13:00-14:30 Concurrent Symposium 2 (Liver) Session 203+204 
Liver transplantation in patients with portal flow insufficiency 
Moderator(s) Clark Andrew Bonham (USA), Shin Hwang (Korea)
13:00-13:20 Management of portal hypertension and thrombosis in patients awaiting LT Bo Hyun Kim (Korea) 
13:20-13:40 Technical tip of portal vein thrombectomy during operation Toshimi Kaido (Japan) 
13:40-14:15 Alternative reconstruction methods using vessels other than the portal vein Deok-bog Moon (Korea) 
14:15-14:30 Video case presentation Young Seok Han (Korea) 
Discussants Dong Jin Joo (Korea), Je Ho Ryu (Korea), Chih-chi Wang (Taiwan), Kenneth Siu Ho Chok (Hong Kong) 
 
13:00-14:30 Concurrent Symposium 3 (Lung) Session 205+206 
Chronic lung allograft dysfunction: a new consensus report of the ISHLT 2019 
Moderator(s) Dong Kwan Kim (Korea), Moo Suk Park (Korea)
13:00-13:30 Review of the consensus report of CLAD 2019 Lianne Singer (Canada) 
13:30-13:45 Pathologic view point of CLAD Beom Jin Lim (Korea) 
13:45-13:55 Cases of institutional experience Woo Hyun Cho (Korea) 
13:55-14:05 Cases of institutional experience Song Yee Kim (Korea) 
14:05-14:30 Panel discussion and Q&A Kyeongman Jeon (Korea), Jieun Park (Korea), Sung-Hoon Park (Korea) 
 
14:30-15:30  Oral presentation 1 (Kidney) Session 201+202 
Moderator(s) Soo Jin Na Choi (Korea), Yeong Hoon Kim (Korea)
14:30-14:42 Association between adherence and intra-patient variability in tacrolimus concentration among kidney transplant recipients: a post hoc analysis of the PRIMA randomized clinical trial Hyunmin Ko (Korea) 
14:42-14:54 Urinary exosomal hemopexin, a validated diagnostic marker for rejection in kidney transplant recipients Jeong-Hoon Lim (Korea) 
14:54-15:06 Outcome of ABO incompatible kidney transplantation in the elderly: a national cohort study using Korean Organ Transplantation Registry data Deok Gie Kim (Korea) 
15:06-15:18 Cardiovascular disease after kidney transplantation: a nationwide study in South Korea Ji Eun Kim (Korea) 
15:18-15:30 Assessment of the usefulness of acute rejection specific transcripts signature in a prospective kidney transplantation cohort Su Woong Jung (Korea) 
 
14:30-15:30  Oral presentation 2 (Liver) Session 203+204 
Moderator(s) Chinburen Jigjidsunren (Mongolia), Youngkyoung You (Korea)
14:30-14:42 Real-World Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of KOTRY Database Shin Hwang (Korea) 
14:42-14:54 Impact of the baseline anti-A/B IgG titer on the clinical outcome in ABO-incompatible liver transplantation Juhan Lee (Korea) 
14:54-15:06 Decreased hepatocellular carcinoma recurrence effect of statins on the living donor liver transplantation patients Okjoo Lee (Korea) 
15:06-15:18 Silent allograft fibrosis in 10-year post-transplantation histology of pediatric liver transplantation: Is it really silent? Seo Hee Lee (Korea) 
15:18-15:30 Pure laparoscopic living donor hepatectomy : single-center experience on 300 patients Eui Soo Han (Korea) 
 
14:30-15:30  Oral presentation 3 (Thoracic) Session 205+206 
Moderator(s) Eun-Seok Jeon (Korea), Jin Gu Lee (Korea)
14:30-14:42 Primary Graft Dysfunction after isolated Heart Transplantation: Incidence, Risk Factors and Clinical Implications Younju Rhee (Korea) 
14:42-14:54 Role of Bronchoalveolar lavage fluid & Serum Aspergillus galactomannan as a predictor of invasive aspergillosis in lung transplantation recipients; A single center study Seung Hyun Yong (Korea) 
14:54-15:06 Prone position: a means of overcoming an oversized donor lung Taehwa Kim (Korea) 
15:06-15:18 Successful treatment of fatal hyperammonemia after lung transplantation JIN OOK JANG (Korea) 
15:18-15:30 Reconstituted trachea from the skin flap in the experimental lung transplant Do Xuan Hai (Vietnam) 
 
15:30-16:30  Coffee break 300 B+C 
 
15:30-16:30  Poster-oral Presentation 01 (Basic) 300B+C 
Moderator(s) Dong Ho Choi (Korea), Junho Chung (Korea)
15:30-15:40 Systems Medicine Modeling, Stability Analysis and Computer Simulation of Hepatitis B Virus Spread by Vaccination Rifaldy Fajar (Indonesia) 
15:40-15:50 Protective effect of Eupatilin against Tacrolimus-induced Nephrotoxicity in LLC-PK1 cells Hyuk Jai Jang (Korea) 
15:50-16:00 Developing experiment for Microtube kit for rat microvascular surgery (MKRMS) facilitating rapid and accurate microvascular anastomosis Sam-Youl Yoon (Korea) 
16:00-16:10 Cytotoxicity of Human Hepatic Intrasinusoidal CD56bright Natural Killer Cells against Hepatocellular Carcinoma Cells Shin Hwang (Korea) 
 
15:30-16:30  Poster-oral Presentation 02 (Kidney) 300B+C 
Moderator(s) Seungyeup Han (Korea), Kyung Hwan Jeong (Korea)
15:30-15:40 Reduced Fixed Dose of Mycophenolate Mofetil with Therapeutic Drug Monitoring in De Novo Renal Transplant Recipients Jang-Hee Cho (Korea) 
15:40-15:50 Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: A retrospective study Deok Gie Kim (Korea) 
15:50-16:00 Characteristics of kidney transplantation in South Korea from 2008 to 2016 Sehoon Park (Korea) 
16:00-16:10 Potential Urinary Proteomic Biomarkers of Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients Hee-Yeon Jung (Korea) 
16:10-16:20 Multiple Drug Resistant Urinary Tract Infection in Kidney Transplant Recipients: A Retrospective Cohort Study Muhammad Tassaduq Khan (Pakistan) 
 
15:30-16:30  Poster-oral Presentation 03 (Kidney) 300B+C 
Moderator(s) Chan-Duck Kim (Korea), Hyung Tae Kim (Korea)
15:30-15:40 Early rise of urinary exosomal BK virus microRNA as a predictive marker for BK virus nephropathy in a prospective kidney transplantation cohort Won Hee Cho (Korea) 
15:40-15:50 Clinical significance of late antibody-mediated rejection without donor-specific anti- HLA antibodies Juhan Lee (Korea) 
15:50-16:00 ​Long-term exposure to particulate matter air pollution and the risk of graft failure and mortality in kidney transplant recipients Yong Chul Kim (Korea) 
16:00-16:10 Universal Prophylaxis with Valganciclovir versus Preemptive Therapy in Minimizing the Risk of Cytomegalovirus Infection and Disease in High and Intermediate Risk Kidney Transplant Recipients: A Single-centered Experience Muhammad Tassaduq Khan (Pakistan) 
16:10-16:20 Pharmacokinetics Clearance of Tacrolimus in Renal Transplant Recipients at Mandalay General Hospital Yi Yi Htun (Myanmar) 
16:20-16:30 Effectiveness of serum beta-2 microglobulin as a tool to evaluate kidney status In Sik Shin (Korea) 
 
15:30-16:30  Poster-oral Presentation 04 (Kidney) 300B+C 
Moderator(s) Myung-gyu Kim (Korea), JeongKye Hwang (Korea)
15:30-15:40 The Korean Organ Transplantation Registry (KOTRY): First Official Kidney Transplantation Report Tai Yeon Koo (Korea) 
15:40-15:50 Effectiveness of an early CMV screening protocol in Thai kidney transplant patients with moderate risk for CMV infection: A preliminary report Nartsiri Ratchawang (Thailand) 
15:50-16:00 Effect of intra-patient variability of tacrolimus level on allograft outcomes in Thai kidney transplant patients Nuttasith Larpparisuth (Thailand) 
16:00-16:10 Urinary NGAL in living kidney donors during long-term follow up; risk of CKD is low Joon Chae Na (Korea) 
16:10-16:20 Malignancy in Kidney Transplant Recipients Than Aye (Myanmar) 
 
15:30-16:30  Poster-oral Presentation 05 (Kidney) 300B+C 
Moderator(s) Dong Ryeol Lee (Korea), Sun Cheol Park (Korea)
15:30-15:40 Usefulness of pharmacokinetic model based tacrolimus dosing in kidney transplant patients with genetic subgroup analysis Hyokee Kim (Korea) 
15:40-15:50 Laparoscopic living donor right nephrectomy: Assessment of outcome and association of BMI to length of right renal vein VU LE NGUYEN (Vietnam) 
15:50-16:00 Laparoscopic Donor Nephrectomy(Where are we?) Aung Kyaw Tun (Myanmar) 
16:00-16:10 Impact of pre-transplant BK viral replication on post-transplant BK viremia in renal transplant recipients Hyejin Mo (Korea) 
16:10-16:20 Incidence, Characteristics and Management of Chronic Active Antibody Mediated Rejection among Kidney Transplant Patients at National Kidney and Transplant Institute from (NKTI) 2005-2016 SUSAN FLORES-LABUNTOG (Philippines) 
16:20-16:30 Effect on Dosage Change and Intrapatient Variability of Tacrolimus Level after Conversion from Mycophenolic Acid to Everolimus among Thai Kidney Transplant Patients with and without CYP3A4/5 Inhibitors Nuttasith Larpparisuth (Thailand) 
 
15:30-16:30  Poster-oral presentation 06 (Liver) 300B+C 
Moderator(s) Bong-Wan Kim (Korea), Deok-bog Moon (Korea)
15:30-15:40 Portal vein thrombosis during liver transplantation: The risk of extra-anatomical portal vein reconstruction Jinsoo Rhu (Korea) 
15:40-15:50 Hepatitis B Vaccination and Entecavir Monotherapy Following Withdrawal of Hepatitis B Immunoglobulin. An Alternative Approach to Prevention of Hepatitis B Reactivation After Liver Transplantation Hye Sung JO (Korea) 
15:50-16:00 Long-term Metabolic Complications in Patients Undergoing Liver Transplantation: A Survey of 651 Cases at a Tertiary Referral Center Mohssen Nassiri Toosi (Iran) 
16:00-16:10 Subclassification of microscopic vascular invasion in hepatocellular carcinoma Incheon Kang (Korea) 
16:10-16:20 Umbelliferone loaded Nano-Lipidic Carriers regulates mitochondrial apoptosis and PhD2 mediated hypoxia in Diethyl nitrosamine induced Hepatocellular Carcinoma Vikas Kumar (India) 
 
15:30-16:30  Poster-oral Presentation 07 (Liver) 300B+C 
Moderator(s) Jai Young Cho (Korea), Young Seok Han (Korea)
15:30-15:40 A novel approach to the management of hepatic artery intimal dissection during living donor liver transplantation Naganathan Selvakumar (India) 
15:40-15:50 Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy Jae Geun Lee (Korea) 
15:50-16:00 Novel technique for graft reduction of left lateral segment: Medial Reduction for pediatric liver transplant recipient Yoshihiro Hirata (India) 
16:00-16:10 Incidentally diagnosed abdominal tuberculosis intraoperatively in liver transplant recipients during Living Donor Liver Transplantation (LDLT) Smita Parakh (India) 
16:10-16:20 Circulating cancer stem cells in hepatocellular carcinoma: a pilot study of prediction for tumor recurrence after living donor liver transplantation Hyeo Seong Hwang (Korea) 
16:20-16:30 Solid lipid nanoparticle of hesperidine exerts diethylnitrosamine/phenobarbitalinduced hepatocellular carcinoma via alteration of PI3K/Akt pathway Deepika Singh (India) 
 
15:30-16:30  Poster-oral Presentation 08 (Liver) 300B+C 
Moderator(s) Donglak Choi (Korea), Dong-Sik Kim (Korea)
15:30-15:40 Analysis of Biliary Complications following Liver Transplantation: A 16-years Experience at a High-volume Transplant Center Nasir Fakhar (Iran) 
15:40-15:50 Clinical differences between steroid sensitive rejection and steroid resistant rejection in liver transplantation Tae Yun Lee (Korea) 
15:50-16:00 Addition of Metformin to Tacrolimus may improve the Treg/Th17 balance compared to Tacrolimus monotherapy in vitro analysis Soon Kyu Lee (Korea) 
16:00-16:10 Survival benefits of living donor liver transplantation for low MELD patients Tiffany Wong (Hong Kong) 
16:10-16:20 Liver transplantation for acute liver failure associated with herbal medicine Tracy YS Cui (Hong Kong) 
 
15:30-16:30  Poster-oral Presentation 09 (Donation) 300B+C 
Moderator(s) Namkyu Choi (Korea), Jae-myeong Lee (Korea)
15:30-15:40 The Effect of "Opt-out" System for Organ Donation after Brain Death on Ethical Legitimacy and Potential Efficacy in a Mathematical Model Young-Nam Roh (Korea) 
15:40-15:50 A survey on Awareness and Attitude Regarding Organ Donation among Medical Professionals, Medical students, Patients and their relatives in Bangladesh A.S.M. Tanim Anwar (Bangladesh) 
15:50-16:00 Expanding Brain death donor transplantation in Mongolia Battsetseg Gonchigjav (Mongolia) 
16:00-16:10 Living kidney donors with metabolic risk has been increasing in South Korea Eunjeong Kang (Korea) 
 
15:30-16:30  Poster-oral Presentation 10 (Thoracic) 300B+C 
Moderator(s) Jae-Joong Kim (Korea), Do Hyung Kim (Korea)
15:30-15:40 Successful lung transplantation in patient with heparin induced thrombocytopenia with thrombosis during extracorporeal membrane oxygenation Hye Ju Yeo (Korea) 
15:40-15:50 First Heart Transplantation at EWHA Medical Center Kyung Jin Kim (Korea) 
15:50-16:00 Analysis about the results of cross-matching and anti-HLA antibodies before lung trasplantatoin Song Yee Kim (Korea) 
16:00-16:10 No more contraindication in special conditions: Clinical midterm outcome of adult heart transplantation using Hepatic C Virus seropositive donors for seronegative recipients Chuan-I Tsao (Taiwan) 
16:10-16:20 Combined trido-lung and kidney transplantation in a patient with rejection and chronic kidney disease after previous redo-lung transplantation Jin-hee Noh (Korea) 
 
16:30-17:30 Concurrent Symposium 4 (Kidney) Session 201+202 
How to improve the outcome of Pediatric kidney transplantation 
Moderator(s) Ik Jin Yun (Korea), Min Hyun Cho (Korea)
16:30-16:50 Recurrent FSGS in Pediatric KT Min Hyun Cho (Korea) 
16:50-17:10 DSA and epitope matching in Pediatric KT Borae G. Park (Korea) 
17:10-17:30 Lower urinary tract problems in Pediatric KT Young Jae Im (Korea) 
 
16:30-17:30 Concurrent Symposium 5 (Liver) Session 203+204 
Special considerations in pediatric liver transplantation 
Moderator(s) Carlos O. Esquivel (USA), Suk Koo Lee (Korea)
16:30-16:50 Donor and graft selection to overcome large-for-size syndrome Seisuke Sakamoto (Japan) 
16:50-17:10 Special surgical techniques in pediatric liver transplantation Carlos O. Esquivel (USA) 
17:10-17:30 Case and discussion Ping Wan (China) 
17:10-17:30 Discussants Nam-Joon Yi (Korea), Shin Hwang (Korea), Artem Monakhov (Russia) 
 
16:30-17:30 Concurrent Symposium 6 (Heart) Session 205+206 
Chronic cardiac allograft rejection 
Moderator(s) Jae-Joong Kim (Korea), Sung-Ho Jung (Korea)
16:30-16:45 Mechanism of chronic cardiac allograft rejection Jin Joo Park (Korea) 
16:45-17:00 Diagnosis and management of chronic cardiac allograft rejection Soo Yong Lee (Korea) 
17:00-17:10 Cases and experience Darae Kim (Korea) 
17:10-17:20 Cases and experience Hyo-In Choi (Korea) 
17:20-17:30 Panel discussion and Q&A Ju Yong Lim (Korea), Mina Kim (Korea) 
 
18:00-20:00  Welcome Dinner Hwangnyongwon 
 
08:00-09:30 Concurrent Symposium 7 (KSN Joint Session) Session 201+202 
Moderator(s) Chul Woo Yang (Korea), Suphamai Bunnapradist (USA)
08:00-08:20 Recurrent hydronephrosis. Why? How to manage?
(이식후 반복적으로 요로결석이 생기는 경우에 고려해야할 사항과 치료방법)
Hyung Duk Kim (Korea) 
08:20-08:40 Asymptomatic bacteriuria. Why? How to manage?
(무증상의 세균뇨가 나오는 경우 치료방법과 실제로 치료해도 계속나오는 경우의 대처)
Kyo Won Lee (Korea) 
08:40-09:00 Hypertensive living donor renal transplantation Hyeon Seok Hwang (Korea) 
09:00-09:20 Bactrim prophylaxis. How much and how long?
(이식초기에 PJP예방을 위한 bactrim투여기간, 용량 및 기타 적응증과 기간)
In O Sun (Korea) 
09:20-09:40 Discussion  
 
08:00-09:30  KOTRY Joint Session Session 203+204 
Moderator(s) Myoung Soo Kim (Korea), Jaeseok Yang (Korea)
08:00-08:30 Allocation of deceased donor kidneys in Australia Phil Clayton (Australia) 
08:30-09:00 Lesson from large-scale genomic studies and research consortia Joon-Yong An (Korea) 
09:00-09:15 Making registry for harmonization in Asian transplant society: Current progress in ASTREG Kenji Yuzawa (Japan) 
09:15-09:30 Making registry for harmonization in Asian transplant society: Current progress in ASTREG Jong Cheol Jeong (Korea) 
 
08:00-09:30 Concurrent Symposium 8 (Basic) Session 205+206 
Moderator(s) Kyungho Choi (Korea), Hyori Kim (Korea)
08:00-08:30 Regulation of CD8 T cell response for mouse minor histocompatibility antigens Eun Young Choi (Korea) 
08:30-09:00 Regulation of high affinity Ab production: a possible role in Ab-mediated rejection Youn Soo Choi (Korea) 
09:00-09:30 Antibody responses in autoimmune diseases Jeehee Youn (Korea) 
 
09:30-10:30 Concurrent Symposium 9 (Pancreas/Islet) Session 201+202 
Recent updates in Pancreas Transplantation 
Moderator(s) Jae Berm Park (Korea), Young Hoon Kim (Korea)
09:30-09:50 Updates in surgical technique Rune Horneland (Norway) 
09:50-10:10 Diagnosis of Rejection in Pancreas Transplantation Byunghyun Choi (Korea) 
10:10-10:30 Metabolic improvement after Pancreas Transplantation Sung Shin (Korea) 
 
09:30-10:30  Oral presentation 4 (Coordination) Session 203+204 
Moderator(s) Bok Nyeo Kim (Korea), Hyun Jung Kim (Korea)
09:30-09:42 뇌사 장기 기증자와 인체 조직 기증자에게 지급된 실제 국가 지원금 Eunsil Jeong (Korea) 
09:42-09:54 Low adherence to immunosuppressants is associated with alcohol drinking among liver transplant recipients Kyung Ock Jeon (Korea) 
09:54-10:06 장기이식수혜자의 건강문해력과 건강관련 삶의 질 간의 관계 Sunyoung Son (Korea) 
10:06-10:18 신장이식 환자에서 이식 전 후 근력의 변화 TAEHEE KIm (Korea) 
10:18-10:30 신장이식환자의 나트륨 섭취량 측정 Sun Young Oh (Korea) 
 
09:30-10:30  Oral Presentation 5 (Basic/Others/Pancreas/Islet) Session 205+206 
Moderator(s) Ik Jin Yun (Korea), Yeong Jin Choi (Korea)
09:30-09:42 Hepatocellular carcinoma research platform from patient-derived xenograft to organoid toward biobanking for precision medicine Shin Hwang (Korea) 
09:42-09:54 Ethical issues for uterine transplantation Evie Kendal (Australia) 
09:54-10:06 The predictive value of real-time elastography in the risk of pancreatic fistula after pancreaticoduodenectomy Yu Cheng (China) 
10:06-10:18 The therapeutic efficacy of water soluble coenzyme Q10 in experimental model of tacrolimus induced diabetes mellitus YI QUAN (Korea) 
10:18-10:30 New approaches for predicting tacrolimus-induced diabetes after transplantation using patient-specific progenitor pancreatic cells from iPSC Sun Woo Lim (Korea) 
 
10:30-11:00  Coffee break 300B+C 
 
11:00-12:00  Keynote lectures 2 (Liver/Basic) Session 300A 
Moderator(s) Junho Chung (Korea), Soon Il Kim (Korea)
11:00-11:30 Bridging therapies to liver transplantation for HCC within the Milan Criteria Francois Durand (France) 
11:30-12:00 Evolution of non-MHC Tissue Transplantation Derry Roopenian (USA) 
 
12:30-13:30  Luncheon Symposium 4 (Chong Kun Dang Pharm.) Session 201+202 
Moderator(s) Yu Seun Kim (Korea), Chang-Kwon Oh (Korea)
12:30-13:00 Safety and efficacy of the step-wise reduction of immunosuppression after kidney transplantation, and its effect on the glucose metabolism Su Hyung Lee (Korea) 
 
12:30-13:30  Luncheon Symposium 5 (Novartis Korea) Session 203+204 
Moderator(s) Hwang, Shin (Korea)
12:30-13:30 Which is the most fittable IS regimen strategy with current status of liver allocation? Jae Geun Lee (Korea) 
 
13:30-14:30  Plenary session 2 Session 300A 
Moderator(s) Suk Koo Lee (Korea), Hong Rae Cho (Korea)
13:30-14:00 Kidney organoid in translational medicine Ryuji Morizane (USA) 
14:00-14:30 Marginal Grafts in Living Donor Liver Transplantation Kyung-Suk Suh (Korea) 
 
10:30-11:00  Coffee break 300B+C 
 
14:30-15:30  Poster-oral Presentation 11 (Kidney) 300B+C 
Moderator(s) Kyu Ha Huh (Korea), Beom Seok Kim (Korea)
14:30-14:40 Improved Serum Vitamin D level and better cardiovascular disease outcomes after Kidney Transplantation JungHwa Ryu (Korea) 
14:40-14:50 Mycophenolic Acid Trough Concentration and Dose are associated with Hematologic Abnormalities but not with Rejection in Kidney Transplant Recipients Hye Won Lee (Korea) 
14:50-15:00 Changes in plasma metabolites after conversion from cyclosporine to tacrolimus in long-term stable kidney transplant recipients Ji-Young Choi (Korea) 
15:00-15:10 Efficacy and safety of percutaneous embolization compared with nephrectomy to treat graft intolerance syndrome in late graft failure patients Su-kyung Kwon (Korea) 
 
14:30-15:30  Poster-oral Presentation 12 (Kidney) 300B+C 
Moderator(s) Jung Hwan Park (Korea), Samuel Lee (Korea)
14:30-14:40 Late intra-patient tacrolimus variability predicts de novo donor-specific antibody and graft loss Juhan Lee (Korea) 
14:40-14:50 Validation of Genetic Polymorphism for New-Onset Diabetes after Renal Transplantation Hyeon Seok Hwang (Korea) 
14:50-15:00 Diagnosis and Immune Modulation for Bk Virus Infection Should Consider Activated T Cell Level, Cytokines Level, and Primary Disease WEN YAO YIN (Taiwan) 
 
14:30-15:30  Poster-oral Presentation 13 (Kidney) 300B+C 
Moderator(s) Sunwoo Kang (Korea), Sun Hyung Joo (Korea)
14:30-14:40 Tertiary lymphoid tissues in protocol biopsies predict progressive graft dysfunction in kidney transplant recipients Yu Ho Lee (Korea) 
14:40-14:50 The influence of the donor kidney weight to recipient body weight on long-term renal graft outcomes Seok Jeong Yang (Korea) 
14:50-15:00 Therapeutic potential of coenzyme Q10 in mitochondrial dysfunction during tacrolimus-induced beta cell injury Kang Luo (Korea) 
15:00-15:10 Prevalence of depression in kidney transplant recipients: a long-term population-based study Semin Cho (Korea) 
15:10-15:20 Health-related quality of life in kidney transplant patients was better than those in chronic kidney disease patients at similar renal function JungHwa Ryu (Korea) 
15:20-15:30 Delayed Graft Function in Kidney Transplants from Deceased Donors with Acute Kidney Injury Chris Tae Young Chung (Korea) 
 
14:30-15:30  Poster-oral Presentation 14 (Kidney) 300B+C 
Moderator(s) Borae G. Park (Korea), Ji Il Kim (Korea)
14:30-14:40 The tacrolimus metabolism affect post-transplant outcome mediating acute rejection and delayed graft function: analysis from Korean Organ Transplantation Registry (KOTRY) data Jong Cheol Jeong (Korea) 
14:40-14:50 Assessment of delta-neutrophil index in living kidney donors: toward understanding the pathogenesis of renal function recovery Jee Soo Park (Korea) 
14:50-15:00 Long term graft outcome after subclinical Banff borderline changes suspicious for acute T cell-mediated rejection Ahram Han (Korea) 
15:00-15:10 Outcome of Living Kidney donors with Microproteinuria: expanding the donor criteria Joon Chae Na (Korea) 
15:10-15:20 Bisphosphonate Use Leads to Better Long-Term Kidney Transplant Outcomes HOON YOUNG CHOI (Korea) 
 
14:30-15:30  Poster-oral Presentation 15 (Liver) 300B+C 
Moderator(s) Jong Man Kim (Korea), Geun Hong (Korea)
14:30-14:40 Necessity and effect of perioperative renal replacement therapy in high MELD score patients waiting for deceased donor liver transplantation Shin Hwang (Korea) 
14:40-14:50 Effects of tenofovir and entecavir on glomerular kidney function in liver transplant patients: a nationwide cohort study Juhan Lee (Korea) 
14:50-15:00 Dual-graft adult living donor liver transplantation with both graft Duct-to-Duct biliary anastomosis : Short-term and long-term outcomes Yong-Kyu Chung (Korea) 
15:00-15:10 Venous outflow congestion is related to poor recur-free survival of hepatocellular carcinoma patients who underwent living donor liver transplantation Jinsoo Rhu (Korea) 
 
14:30-15:30  Poster-oral Presentation 16 (Liver) 300B+C 
Moderator(s) Jae Do Yang (Korea), Kwang-Woong Lee (Korea)
14:30-14:40 Various technique for bile duct division in pure laparoscopic donor hepatectomy Jeong-Moo Lee (Korea) 
14:40-14:50 Clinical Application of Neutrophil to Lymphocyte Ratio in predicting 3-month Mortality among Cirrhotic Patients on the Liver Transplant Waiting List: A Cohort Study Mohssen Nassiri Toosi (Iran) 
14:50-15:00 Image-guided surgery based on 2D illustrations and 3D printed model of donor anatomy during living donor hepatectomy Jinsoo Rhu (Korea) 
15:00-15:10 Renal safety of entecavir and tenofovir with hepatitis B immunoglobulin in liver transplant patients Juhan Lee (Korea) 
15:10-15:20 Hepatic Progenitor Cells as Predictors of Response to Antiviral Therapy in Chronic Hepatitis C Viral Infection Aly Kassem (Egypt) 
15:20-15:30 Transplantable bile duct seeded with cholangiocytes derived from human chemically derived liver progenitor cells Elina Maria Buisson (Korea) 
 
14:30-15:30  Poster-oral Presentation 17 (Liver) 300B+C 
Moderator(s) Gi Hong Choi (Korea), Jeong Won Jang (Korea)
14:30-14:40 Validation of ADV Score as a Quantifiable Prognostic Biomarker for Hepatocellular Carcinoma Recurrence After Liver Transplantation Shin Hwang (Korea) 
14:40-14:50 Living donor liver transplant for ACLF3 is challenging but has similar and acceptable outcomes Sapana Verma (India) 
14:50-15:00 Pure laparoscopic versus open right hepatectomy in live liver donors: a propensity score matched analysis Suk Kyun Hong (Korea) 
 
14:30-15:30  Poster-oral Presentation 18 (Others) 300B+C 
Moderator(s) Jang-Hee Cho (Korea), Kyung Hwan Jeong (Korea)
14:30-14:40 Effects of Short-term Preservation Solutions on the Viability and Potency of Canine Adipose-Derived Mesenchymal Stem Cells Tania Sultana (Korea) 
14:40-14:50 Effect of Gymnema sylvestre on pancreatic β-cell regeneration Senthil Kumar Subramani (India) 
14:50-15:00 Public awareness survey on Organ Donation and Transplantation Battsetseg Gonchigjav (Mongolia) 
15:00-15:10 Differential characteristics of recipients with non-infectious fever following pancreas transplantation with antithymocyte globulin induction Ye Eun Shim (Korea) 
15:10-15:20 Association of Antibody-secreting Cells with Allograft Rejection in Kidney Transplantation Minjeong Nam (Korea) 
15:20-15:30 Validation of Rapid Optimized Flow Cytometric Crossmatch Assay Sangyoon Lee (Korea) 
 
14:30-15:30  Poster-oral Presentation 19 (Coordination) 300B+C 
Moderator(s) Hyung Sook Kim (Korea), Jaesook Oh (Korea)
14:30-14:40 사회문제와 언론 보도가 기증희망등록과 실제 기증에 미치는 영향 Jungsun Kim (Korea) 
14:40-14:50 통보된 뇌사추정자의 관리현황과 기증 증가를 위한 방안 Eunsuk Yu (Korea) 
14:50-15:00 단일 종합병원 뇌사자 신장이식수혜자의 대기기간과 매칭빈도수 분석 JUNG JA HONG (Korea) 
 
15:30-16:30  Concurrent Symposium 10 (Xenotransplantation) Session 201+202 
Moderator(s) Nam Hyung Kim (Korea), Curie Ahn (Korea)
15:30-15:45 Status of Xenotransplantation for 20 years in Korea Curie Ahn (Korea) 
15:45-16:00 Current status of Clinical Pancreatic Islet Xenotransplantation Chung-Gyu Park (Korea) 
16:00-16:15 Improvement safety and efficiency of xeno islet transplantation Hyojun Park (Korea) 
16:15-16:30 Ethical and legal aspect of the xenotransplantation So Yoon Kim (Korea) 
 
15:30-15:50 Update 1 (Liver) Session 203+204 
Small bowel transplantation 
Moderator(s) Myoung Soo Kim (Korea)
15:30-15:50 Update on intestinal transplantation Clark Andrew Bonham (USA) 
 
15:50-16:30 Concurrent Symposium 11 (Liver) Session 203+204 
Medical management for liver transplantation 
Moderator(s) Hee Chul Yu (Korea), Francois Durand (France)
15:50-16:10 Management of HCV in pre- and post-transplant situation W. Ray Kim (USA) 
16:10-16:30 Systemic therapy for HCC in liver transplantation Jeong Won Jang (Korea) 
 
15:50-16:30 Concurrent Symposium 12 (Coordination) Session 205+206 
Moderator(s) In Ok Kim (Korea), In-hye Song (Korea)
15:30-15:50 Processes and problems for the management of brain death donor Yong Min Lee (Korea) 
15:50-16:10 Review of living organ transplantation approval procedures Jieun Lee (Korea) 
16:10-16:20 Q & A  
16:20-16:30 Assembly In Ok Kim (Korea) 
 
16:30-17:30  Award Ceremony and Closing Session 201+202